The role of metabolomic markers for patients with infectious diseases: implications for risk stratification and therapeutic modulation (Q47662026)

4 February 2018

http://europepmc.org/abstract/MED/29316826

title

The role of metabolomic markers for patients with infectious diseases: implications for risk stratification and therapeutic modulation (English)

1 reference

4 February 2018

http://europepmc.org/abstract/MED/29316826

author

Peter Neyer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29316826 AND SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Seline Zurfluh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29316826 AND SRC:MED&resulttype=core&format=json

3 June 2020

Thomas Baumgartner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29316826 AND SRC:MED&resulttype=core&format=json

3 June 2020

Marc A Meier

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29316826 AND SRC:MED&resulttype=core&format=json

3 June 2020

Manuel Ottiger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29316826 AND SRC:MED&resulttype=core&format=json

3 June 2020

Alaadin Voegeli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29316826 AND SRC:MED&resulttype=core&format=json

3 June 2020

Luca Bernasconi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29316826 AND SRC:MED&resulttype=core&format=json

3 June 2020

Beat Mueller

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29316826 AND SRC:MED&resulttype=core&format=json

3 June 2020

Philipp Schuetz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29316826 AND SRC:MED&resulttype=core&format=json

3 June 2020

publication date

9 January 2018

1 reference

4 February 2018

http://europepmc.org/abstract/MED/29316826

published in

Expert Review of Anti-infective Therapy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29316826 AND SRC:MED&resulttype=core&format=json

3 June 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29316826 AND SRC:MED&resulttype=core&format=json

3 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29316826 AND SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

133-142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29316826 AND SRC:MED&resulttype=core&format=json

Systematic functional analysis of the yeast genome

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Metabolomics and Its Application to Acute Lung Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

New frontiers in metabolomics: from measurement to insight

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Navigating freely-available software tools for metabolomics analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Can NMR solve some significant challenges in metabolomics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Metabolomics as a Driver in Advancing Precision Medicine in Sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Recent Advances in NMR-Based Metabolomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Mass spectrometry for the discovery of biomarkers of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Emerging new strategies for successful metabolite identification in metabolomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Metabolomics beyond spectroscopic databases: a combined MS/NMR strategy for the rapid identification of new metabolites in complex mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Harmful molecular mechanisms in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

The interplay between central metabolism and innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Are admission procalcitonin levels universal mortality predictors across different medical emergency patient populations? Results from the multi-national, prospective, observational TRIAGE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Procalcitonin-guided diagnosis and antibiotic stewardship revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

The role of immune and metabolic biomarkers for improved management of sepsis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Metabolite Profiles in Sepsis: Developing Prognostic Tools Based on the Type of Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Targeted metabolomics for discrimination of systemic inflammatory disorders in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Lipid mediators of inflammation as novel plasma biomarkers to identify patients with bacteremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Metabolic profiling of serum samples by 1H nuclear magnetic resonance spectroscopy as a potential diagnostic approach for septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Lipid metabolites as potential diagnostic and prognostic biomarkers for acute community acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Metabolic Profiling in Patients with Pneumonia on Intensive Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Severe community-acquired pneumonia: optimal management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Mortality prediction in patients with severe septic shock: a pilot study using a target metabolomics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Metabolomic derangements are associated with mortality in critically ill adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

An integrated clinico-metabolomic model improves prediction of death in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Pharmaco-metabonomic phenotyping and personalized drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: towards personalized drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Characterization of a metabolomic profile associated with responsiveness to therapy in the acute phase of septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Pharmacometabolomics of l-carnitine treatment response phenotypes in patients with septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Role of indoleamine 2,3-dioxygenase in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

RETRACTED ARTICLE: Sepsis-induced elevation in plasma serotonin facilitates endothelial hyperpermeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

l-Kynurenine Its synthesis and possible regulatory function in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Thrombocytopenia impairs host defense in gram-negative pneumonia-derived sepsis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Activation of the tryptophan/serotonin pathway is associated with severity and predicts outcomes in pneumonia: results of a long-term cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Activation of the Serotonin Pathway is Associated with Poor Outcome in COPD Exacerbation: Results of a Long-Term Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Nitrotyrosine as a new marker for endogenous nitrosation and nitration of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Accelerated reaction of nitric oxide with O 2 within the hydrophobic interior of biological membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Reversal of the superoxide dismutase reaction revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Nitrotyrosine level was associated with mortality in patients with acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Aldosterone secretion in patients with septic shock: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Hypothalamic-pituitary-adrenal axis in lethal canine Staphylococcus aureus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Time-dependent association of glucocorticoids with adverse outcome in community-acquired pneumonia: a 6-year prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

The L-arginine-nitric oxide pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Asymmetric dimethylarginine in chronic obstructive pulmonary disease (ADMA in COPD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Arginase and pulmonary diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

The role of asymmetric and symmetric dimethylarginines in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Asymmetric dimethylarginine predicts survival in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

Free and Total Cortisol Levels as Predictors of Severity and Outcome in Community-acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

What role can metabolomics play in the discovery and development of new medicines for infectious diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2018.1426460

10.1080/14787210.2018.1426460

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29316826 AND SRC:MED&resulttype=core&format=json

3 June 2020

1 reference